SECURITIES PURCHASE AGREEMENT BY AND AMONG BIODESIX, INC., AND THE PURCHASERS AS SET FORTH HEREIN APRIL 5, 2024Securities Purchase Agreement • April 9th, 2024 • Biodesix Inc • Services-medical laboratories
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of April 5, 2024, by and among Biodesix, Inc., a Delaware corporation (the “Company”), and the entities listed on Exhibit A attached to this Agreement (each, a “Purchaser” and together, the “Purchasers”).
17,391,832 Shares BIODESIX, INC. COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • April 9th, 2024 • Biodesix Inc • Services-medical laboratories • New York
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 9th, 2024 • Biodesix Inc • Services-medical laboratories
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of April 5, 2024, is entered into by and among Biodesix, Inc., a Delaware corporation (the “Company”), and the several investors signatory hereto (individually as an “Investor” and collectively together with their respective permitted assigns, the “Investors”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement by and among the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
